Related Experiment Video
Updated: Oct 5, 2025
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Liver manifestations and complications in inflammatory bowel disease: A review
Rui Gaspar1, Catarina Castelo Branco2, Guilherme Macedo3
1Department of Gastroenterology and Hepatology, Centro Hospitalar de São João, Porto 4200, Portugal. ruilopesgaspar@gmail.com.
Abstract:
Hepatobiliary manifestations are common in inflammatory bowel disease (IBD), with 30% of patients presenting abnormal liver tests and 5% developing chronic liver disease. They range from asymptomatic elevated liver tests to life-threatening disease and usually follow an independent course from IBD. The pathogenesis of liver manifestations or complications and IBD can be closely related by sharing a common auto-immune background (in primary sclerosing cholangitis, IgG4-related cholangitis, and autoimmune hepatitis), intestinal inflammation (in portal vein thrombosis and granulomatous hepatitis), metabolic impairment (in non-alcoholic fatty liver disease or cholelithiasis), or drug toxicity (in drug induced liver injury or hepatitis B virus infection reactivation). Their evaluation should prompt a full diagnostic workup to identify and readily treat all complications, improving management and outcome.
Insights
Inflammatory bowel disease (IBD) frequently causes liver issues, from abnormal liver tests to chronic liver disease. Early diagnosis and treatment of these hepatobiliary manifestations are crucial for better patient outcomes.
Area of Science:
- Gastroenterology and Hepatology
- Immunology
Background:
- Hepatobiliary manifestations are common in inflammatory bowel disease (IBD), affecting up to 30% of patients with abnormal liver tests and 5% with chronic liver disease.
- These liver complications often course independently of IBD activity but share common pathogenic links.
Purpose of the Study:
- To review the spectrum of hepatobiliary manifestations in IBD.
- To elucidate the diverse pathogenetic mechanisms linking IBD and liver disease.
- To emphasize the importance of comprehensive evaluation and timely management.
Main Methods:
- Literature review of studies on IBD and hepatobiliary diseases.
- Analysis of shared etiological factors including autoimmunity, inflammation, metabolic dysfunction, and drug toxicity.
- Synthesis of diagnostic approaches and management strategies.
Main Results:
- Hepatobiliary manifestations in IBD range from mild liver test abnormalities to severe liver disease.
- Pathogenesis involves shared autoimmune backgrounds (e.g., PSC, IgG4-cholangitis, AIH), intestinal inflammation (e.g., PVT, granulomatous hepatitis), metabolic factors (e.g., NAFLD, gallstones), and drug toxicity or viral reactivation.
- These conditions require thorough diagnostic workup.
Conclusions:
- Hepatobiliary complications are a significant concern in IBD patients.
- Understanding the diverse pathogenetic links is key to effective management.
- Prompt diagnosis and treatment of liver complications can improve overall patient outcomes.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...